HF
UTHR icon

HRT Financial’s United Therapeutics UTHR Stock Holding History

HRT Financial’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.6M Buy
66,842
+3,445
+5% +$1.72M 0.1% 167
2025
Q4 		$30.9M Sell
63,397
-12,241
-16% -$5.7M 0.1% 146
2025
Q3 		$31.7M Buy
+75,638
New +$25.4M 0.12% 106
2025
Q1 		– Sell
-9,528
Closed -$3.36M – 3442
2024
Q4 		$3.36M Sell
9,528
-1,724
-15% -$634K 0.02% 544
2024
Q3 		$4.03M Buy
+11,252
New +$3.8M 0.02% 561
2024
Q2 		– Sell
-17,306
Closed -$3.98M – 3160
2024
Q1 		$3.98M Buy
17,306
+11,714
+209% +$2.64M 0.02% 332
2023
Q4 		$1.23M Buy
5,592
+960
+21% +$221K 0.01% 886
2023
Q3 		$1.05M Buy
4,632
+1,807
+64% +$416K 0.01% 940
2023
Q2 		$623K Sell
2,825
-32,876
-92% -$7.28M 0.01% 1242
2023
Q1 		$8M Buy
35,701
+8,722
+32% +$2.15M 0.1% 178
2022
Q4 		$7.5M Buy
26,979
+24,041
+818% +$6.07M 0.11% 175
2022
Q3 		$615K Buy
+2,938
New +$657K 0.01% 1303
2022
Q2 		– Sell
-18,209
Closed -$3.27M – 3773
2022
Q1 		$3.27M Buy
18,209
+13,493
+286% +$2.57M 0.02% 425
2021
Q4 		$1.02M Sell
4,716
-10,107
-68% -$1.98M 0.01% 1097
2021
Q3 		$2.74M Buy
+14,823
New +$2.92M 0.02% 551
2021
Q2 		– Sell
-5,963
Closed -$997K – 3572
2021
Q1 		$997K Buy
+5,963
New +$994K 0.01% 1161
2020
Q3 		– Sell
-10,904
Closed -$1.32M – 2391
2020
Q2 		$1.32M Buy
+10,904
New +$1.23M 0.04% 457
2020
Q1 		– Sell
-2,312
Closed -$203K – 1383
2019
Q4 		$203K Buy
+2,312
New +$203K 0.01% 940
2019
Q3 		– Sell
-21,567
Closed -$1.68M – 1615
2019
Q2 		$1.68M Buy
+21,567
New +$2.02M 0.11% 198

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

HRT Financial's UTHR Position: Q1 2026 in Review

HRT Financial increased its United Therapeutics (UTHR) stake by 5.4% in Q1 2026, buying an estimated $1.72M and bringing the position to 66,842 shares worth $39.6M. The position accounts for 0.1% of the portfolio, ranked #167.

HRT Financial first reported a position in UTHR in Q2 2019 and has held it in 19 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • HRT Financial held 66,842 shares of United Therapeutics worth $39.6M as of Q1 2026.
  • HRT Financial bought 3,445 United Therapeutics shares in Q1 2026, an estimated $1.72M.
  • United Therapeutics made up 0.1% of HRT Financial's portfolio in Q1 2026, its #167 holding.
  • HRT Financial first reported a position in United Therapeutics in Q2 2019 and has held it in 19 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.